Impostor syndrome prevalence in oncology pharmacists is a complex topic that is not well described.
|Articles|January 1, 2004
- Volume 0 0
Measuring Heart Health
Advertisement
Measuring Heart Health
In an effort to determine the bestmeasure of an individual?s heart health, researchers looked atlow-density lipoprotein (LDL) cholesterol (or "bad" cholesterol) andapolipoprotein B (ApoB). To investigate, the researchers looked at 1522people in the Insulin Resistance Atherosclerosis Study. Theparticipants went through examinations for heart disease, stroke, anddiabetes risk factors. They were divided into 2 groups: 1 group would betreated based on their LDL levels, and the other group would be treatedbased on their ApoB levels. The findings, published recently in Circulation:Journal of the American Heart Association,included the following:
? 15% of the people who would betreated based on LDL would not be treated based on ApoB
?25% of the people who would notbe treated based on LDL would be treated based on ApoB
? Overall, about 1 in 5 peoplewould have had a different treatment recommendation if the decision were based on ApoBinstead of LDL
Articles in this issue
almost 23 years ago
GER Is Common Among Children with Bronchial Asthmaalmost 23 years ago
Not All GERD Patients Are Alikealmost 23 years ago
Chronic Constipation Makes Headlinesalmost 23 years ago
Dyspepsia and Gastric Emptying in Diabeticsalmost 23 years ago
New Indications: 2003almost 23 years ago
Can You Read These Rxs? Answersalmost 23 years ago
Compounding Hotlinealmost 23 years ago
Sleep Apnea Is Tied to Depression?almost 23 years ago
Women Are Shortchanged on Getting Shut-Eyealmost 23 years ago
RLS Runs in the FamilyAdvertisement
Related to this article
This quiz was created in collaboration with PTCE™.
Pharmacy professionals can leverage LinkedIn to build a professional brand, expand meaningful connections, share expertise, and create opportunities for career growth.
An Italian pharmacy student offers an inside look at pharmacy education in Italy, from admission and coursework to oral exams and professional training.
Pharmacy students can create greater career optionality by viewing the PharmD as a professional platform rather than a predetermined job title.
Isatuximab on-body injector enables quick, hyaluronidase-free subcutaneous dosing, reducing reactions and easing multiple myeloma clinic workflows.
A summer PCAC vote pushes 6 peptide families toward the 503A bulks list—but the FDA's decision is still pending.
Pharmacy teams can prevent early discontinuation by setting clear expectations for when—and how—a medication's benefit will become apparent.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Peptide Compounding Is Evolving: What Pharmacists Need to Know Now
2
VAX-31 Meets All Primary End Points vs PCV20 and PCV21 in Pivotal Phase 3 OPUS-1 Trial
3
Dostarlimab Receives FDA Accelerated Approval for MSI-H/dMMR Locally Advanced Rectal Cancer
4
FDA Approves Phentolamine Eye Drop for Presbyopia in Adults
5